首页> 外文期刊>MEDICC review >RT-PCR Usefulness in Microbiological Discharge Decisions for COVID-19 Patients
【24h】

RT-PCR Usefulness in Microbiological Discharge Decisions for COVID-19 Patients

机译:RT-PCR在Covid-19患者微生物排放决策中的用量

获取原文
获取外文期刊封面目录资料

摘要

The Cuban Ministry of Public Health’s Protocol for Attention to COVID-19 Patients establishes that case confirmations are determined by positive virological tests of persons with and without symptoms.[1] These studies are carried out for SARSCoV-2 by real-time polymerase chain reaction (RT-PCR) in specimens of respiratory mucosa collected via nasopharyngeal swab. The Protocol also establishes three types of discharge: microbiological (based on negative RT-PCR), clinical-imaging (no signs or symptoms and negative chest scan) and epidemiological (14 days after negative RT-PCR). A microbiological release from hospital is warranted when a patient tests negative by RT-PCR at nine days after testing positive.
机译:古巴公共卫生部注意关注Covid-19患者的议定书建立了案例确认是通过患有和无症状的人的积极病毒学考验来确定。[1]通过鼻咽拭子收集的呼吸粘膜标本中的实时聚合酶链反应(RT-PCR)对这些研究进行SARSCOV-2。该方案还建立了三种类型的放电:微生物学(基于阴性RT-PCR),临床成像(无症状或症状和负胸部扫描)和流行病学(阴性RT-PCR后14天)。当患者在测试阳性后九天的RT​​-PCR测试患者时,保证医院的微生物释放。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号